2023-07-16-世界卫生组织-Immunization_Andorra_2023_country_profile_16页_329kb

报告摘要

Andorra WHO and UNICEF Immunization Coverage Summary

Overview

This document details the immunization coverage estimates for Andorra based on WHO and UNICEF data, revised for 2022 and based on information received by June 26, 2023. The next revision is scheduled for July 15, 2024. Estimates are country-specific and may incorporate empirical data or adjusted calculated values, with a focus on varying quality and potential biases. Coverage data is provided for various vaccines from 2011 to 2022.

Key Vaccines Covered

BCG: Estimated coverage percentages show consistency but no accepted empirical data available in most years.
DTP1: Coverage generally around 96-99% since 2011, informed by DTP3 estimates.
DTP3: High coverage (96-99%) with no independent validation, confidence level medium.
Pol3: Coverage similar to DTP3, high rates (96-99%), confidence level medium.
IPV1: Coverage began in 2015, increasing from unavailable or low in early years to 99% by 2022.
MCV1: Coverages ranges from 95-100%, confidence level medium.
MCV2: Coverage generally high (88-97%), with some interpolation used.
RCV1: Estimates based on MCV1, coverage high (96-99%).
HepBB: Coverage from 93-95% before removal from schedule in 2017, confidence level medium.
HepB3: Coverage around 94-99%, confidence level medium.
Hib3: Coverage high (96-99%), confidence level medium.
RotaC: No data available for Andorra.
PcV3: Coverage introduced in 2014, rising from no data to 92-96%.

General Trends

Overall, most vaccines show high and stable coverage (>95%) across the review period, indicating robust immunization programs. However, many estimates lack recently validated data, with confidence levels typically rated as medium (GoC: ••), reflecting reliance on reported data and potential biases. Estimates should be assessed cautiously based on specific objectives. Since the data stands unverified in many cases, independent empirical assessments are recommended for confirmation.

Further information available at:

展开完整摘要